CADTH Canadian Drug Expert Committee recommendation : indication : giant cell arteritis. Tocilizumab (Actemra - Hoffmann-La Roche Limited)

MLA

CADTH Canadian Drug Expert Committee. CADTH Canadian Drug Expert Committee recommendation : indication : giant cell arteritis. Tocilizumab (Actemra - Hoffmann-La Roche Limited). Final. Ottawa, ON : CADTH, 2018.

APA

CADTH Canadian Drug Expert Committee. (2018). CADTH Canadian Drug Expert Committee recommendation : indication : giant cell arteritis. Tocilizumab (Actemra - Hoffmann-La Roche Limited). Final. Ottawa, ON : CADTH.

Chicago

CADTH Canadian Drug Expert Committee. CADTH Canadian Drug Expert Committee recommendation : indication : giant cell arteritis. Tocilizumab (Actemra - Hoffmann-La Roche Limited). Final. Ottawa, ON : CADTH, 2018.